These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36577870)

  • 1. Associations between paraclinical parameters, symptoms and quality of life in patients with acromegaly: a cross sectional study.
    Gliga MC; Reti Z; Gliga C; Pascanu IM
    J Patient Rep Outcomes; 2022 Dec; 6(1):130. PubMed ID: 36577870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between pain, arthropathy and health-related quality of life in patients suffering from acromegaly. A cross-sectional study.
    Alito A; Basile GC; Bruschetta D; Berescu GL; Cavallaro F; Postorino AD; Scarcella E; Ragonese M; Cannavò S; Tisano A
    Folia Med (Plovdiv); 2023 Feb; 65(1):37-45. PubMed ID: 36855972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS study.
    Caron PJ; Bevan JS; Petersenn S; Houchard A; Sert C; Webb SM;
    Pituitary; 2016 Apr; 19(2):149-57. PubMed ID: 26603536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly.
    T'Sjoen G; Bex M; Maiter D; Velkeniers B; Abs R
    Eur J Endocrinol; 2007 Oct; 157(4):411-7. PubMed ID: 17893254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire.
    Rowles SV; Prieto L; Badia X; Shalet SM; Webb SM; Trainer PJ
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3337-41. PubMed ID: 15755865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL).
    Trepp R; Everts R; Stettler C; Fischli S; Allemann S; Webb SM; Christ ER
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):103-10. PubMed ID: 15963069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of Life in Patients with Acromegaly - A Romanian Single Center Cross-Sectional Study.
    Scânteie CL; Leucuţa DC; Ghervan CMV
    Acta Endocrinol (Buchar); 2021; 17(1):42-50. PubMed ID: 34539909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of Life and its Determinants in Patients With Treated Acromegaly: A Cross-Sectional Nationwide Study in China.
    Guo X; Wang K; Yu S; Gao L; Wang Z; Zhu H; Xing B; Zhang S; Dong D
    J Clin Endocrinol Metab; 2021 Jan; 106(1):211-225. PubMed ID: 33079177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of Illness Acceptance Among Other Factors Affecting Quality of Life in Acromegaly.
    Jawiarczyk-Przybyłowska A; Szcześniak D; Ciułkowicz M; Bolanowski M; Rymaszewska J
    Front Endocrinol (Lausanne); 2019; 10():899. PubMed ID: 32010060
    [No Abstract]   [Full Text] [Related]  

  • 10. The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoL.
    Yoshida K; Fukuoka H; Matsumoto R; Bando H; Suda K; Nishizawa H; Iguchi G; Ogawa W; Webb SM; Takahashi Y
    Pituitary; 2015 Dec; 18(6):876-83. PubMed ID: 26123761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric disorders and anger in patients with controlled acromegaly.
    Prencipe N; Motta G; Crespi CM; Albert U; Berton AM; Bona C; Bioletto F; Varaldo E; Cuboni D; Gasco V; Ghigo E; Maina G; Grottoli S
    Minerva Endocrinol (Torino); 2023 Apr; ():. PubMed ID: 37021924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly.
    Hua SC; Yan YH; Chang TC
    Eur J Endocrinol; 2006 Dec; 155(6):831-7. PubMed ID: 17132752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: Results from a 5-years prospective study.
    Kyriakakis N; Lynch J; Gilbey SG; Webb SM; Murray RD
    Clin Endocrinol (Oxf); 2017 Jun; 86(6):806-815. PubMed ID: 28316090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Applicability of Patient- and Clinician-Reported Outcome Tools in the Management of Patients With Acromegaly.
    Herman R; Goričar K; Janež A; Jensterle M
    Endocr Pract; 2022 Jul; 28(7):678-683. PubMed ID: 35421593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acromegaly improves quality of life, measured by AcroQol.
    Paisley AN; Rowles SV; Roberts ME; Webb SM; Badia X; Prieto L; Shalet SM; Trainer PJ
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):358-62. PubMed ID: 17555502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical Parameters.
    Geraedts VJ; Andela CD; Stalla GK; Pereira AM; van Furth WR; Sievers C; Biermasz NR
    Front Endocrinol (Lausanne); 2017; 8():40. PubMed ID: 28316591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study.
    Sardella C; Lombardi M; Rossi G; Cosci C; Brogioni S; Scattina I; Webb SM; Gasperi M; Martino E; Bogazzi F
    J Endocrinol Invest; 2010 Jan; 33(1):20-5. PubMed ID: 20203538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Klotho: a possible predictor of quality of life in acromegaly patients.
    Coopmans EC; El-Sayed N; Frystyk J; Magnusson NE; Jørgensen JOL; van der Lely AJ; Janssen JAMJL; Muhammad A; Neggers SJCMM
    Endocrine; 2020 Jul; 69(1):165-174. PubMed ID: 32333268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience.
    Salvatori R; Maffei P; Webb SM; Brue T; Loftus J; Valluri SR; Gomez R; Wajnrajch MP; Fleseriu M
    Pituitary; 2022 Jun; 25(3):420-432. PubMed ID: 35022929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life after long-term biochemical control of acromegaly.
    Kimball A; Dichtel LE; Yuen KCJ; Woodmansee WW; Haines MS; Nachtigall LB; Swearingen B; Jones P; Tritos NA; Sharpless JL; Kaiser UB; Gerweck A; Miller KK
    Pituitary; 2022 Jun; 25(3):531-539. PubMed ID: 35476257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.